F19.92

Clinical Causes: Use of unspecified psychoactive substances, which may include unidentified or unreported drugs Accidental ingestion of psychoactive substances Intentional misuse or recreational use of substances without specific identification Poly-drug use where the exact substances are not clearly identified Lack of knowledge about the composition or effects of ingested substances

Key Symptoms: Altered mental state, such as confusion or agitation Impaired coordination and motor skills Altered consciousness, including drowsiness or coma Physical signs like dilated or constricted pupils, rapid or slowed heart rate Nausea, vomiting, or gastrointestinal discomfort Visual or auditory hallucinations Anxiety, paranoia, or erratic behavior Potential respiratory distress or abnormal vital signs

Diagnosis Path: Diagnosis typically involves a comprehensive clinical assessment, including a detailed medical history and physical examination. Laboratory tests, such as blood or urine analysis, may assist in detecting the presence of psychoactive substances. However, given the unspecified nature of the drug involved, clinicians often rely on observable symptoms and patient reports to guide diagnosis. It is important to differentiate intoxication from other medical or psychiatric conditions that may present similarly.

Treatment Protocols: Management of intoxication under ICD-10 F19.92 usually involves supportive and symptomatic care. This may include ensuring airway, breathing, and circulation are stable, monitoring vital signs, and addressing specific symptoms. In some cases, medications may be administered to counteract effects or manage agitation. Treatment also involves preventing further substance use, providing mental health support, and coordinating follow-up care to address underlying issues related to substance use. The focus is on patient safety and stabilization, with referral to specialized services as needed.